Agency Information Collection Activities: Submission for OMB Review; Comment Request, 77876-77878 [2024-21789]
Download as PDF
<![CDATA[
77876
Federal Register / Vol. 89, No. 185 / Tuesday, September 24, 2024 / Notices
Publications: Protective human
monoclonal antibodies target conserved
sites of vulnerability on the underside of
influenza virus neuraminidase.
Lederhofer, Julia et al. Immunity,
Volume 57, Issue 3, 574–586.e7.
Intellectual Property: PCT/US2023/
071194 filed 28 July 2023 (NIH Ref. No.
E–177–2022).
Licensing Contact: To license this
technology, please contact Haiqing Li at
240–627–3708, or lihai@mail.nih.gov,
and reference E–177–2022.
Dated: September 18, 2024.
Christopher M. Kornak,
Acting Deputy Director, Technology Transfer
and Intellectual Property Office, National
Institute of Allergy and Infectious Diseases.
[FR Doc. 2024–21742 Filed 9–23–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
lotter on DSK11XQN23PROD with NOTICES1
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Time-Sensitive
Obesity review.
Date: October 29, 2024.
Time: 2:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, NIDDK
Democracy II, Suite 7000A, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Michele L. Barnard, Ph.D.,
Scientific Review Officer, National Institute
of Diabetes and Digestive and Kidney,
National Institute of Health, 6707 Democracy
Boulevard, Rm. 7353, Bethesda, MD 20892–
2542, (301) 594–8898, barnardm@
extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
VerDate Sep<11>2014
18:07 Sep 23, 2024
Jkt 262001
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: September 18, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–21737 Filed 9–23–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Periodically, the Substance Abuse and
Mental Health Services Administration
(SAMHSA) will publish a summary of
information collection requests under
OMB review, in compliance with the
Paperwork Reduction Act (44 U.S.C.
chapter 35). To request a copy of these
documents, call the SAMHSA Reports
Clearance Officer on (240) 276–0361.
Proposed Project: New: The Center for
Substance Abuse Prevention Online
Reporting Tool and Grant Programmatic
Progress Report to replace Division of
State Programs—Management Reporting
Tool (DSP–MRT) (OMB No. 0930–0354).
The Substance Abuse and Mental
Health Services Administration’s
(SAMHSA), Center for Substance Abuse
Prevention (CSAP) is requesting
approval from the Office of Management
and Budget (OMB) to monitor CSAP
discretionary grant programs through
administration of a suite of data
collection instruments for grant
compliance and programmatic
performance monitoring.
This package describes the data
collection activities and proposed
instruments. Grant compliance
monitoring will be conducted via a
single data collection instrument to be
completed by all CSAP discretionary
grant recipients. Programmatic
performance monitoring will be
conducted via a suite of data collection
instruments with each instrument
tailored to a specific CSAP discretionary
program. This request for data collection
will replace OMB No. 0930–0354:
Division of State Programs—
Management Reporting Tool.
CSAP intends to monitor six grant
programs through this data collection
effort:
• Strategic Prevention Framework—
Partnerships for Success (SPF–PFS): The
purpose of the SPF–PFS program is to
help reduce the onset and progression of
PO 00000
Frm 00066
Fmt 4703
Sfmt 4703
substance misuse and its related
problems by supporting the
development and delivery of state and
community substance misuse
prevention and mental health
promotion services. This program is
intended to promote substance use
prevention throughout a state
jurisdiction for individuals and families
by building and expanding the capacity
of local community prevention
providers to implement evidence-based
programs. In addition, the program is
intended to expand and strengthen the
capacity of local community prevention
providers to implement evidence-based
prevention programs. With this
program, SAMHSA aims to strengthen
state and community level prevention
capacity to identify and address local
substance use prevention concerns,
such as underage drinking, marijuana,
tobacco, electronic cigarettes, opioids,
methamphetamine, and heroin.
• Sober Truth on Preventing
Underage Drinking (STOP Act): The
purpose of this program is to prevent
and reduce alcohol use among youth
and young adults ages 12–20 in
communities throughout the United
States through evidence-based
screening, programs and curricula, brief
intervention strategies, consistent policy
enforcement, and environmental
changes that limit underage access to
alcohol as authorized by 42 U.S.C.
290bb–25b. The program aims to: (1)
address norms regarding alcohol use by
youth, (2) reduce opportunities for
underage drinking, (3) create changes in
underage drinking enforcement efforts,
(4) address penalties for underage use,
and/or (5) reduce negative consequences
associated with underage drinking.
• Strategic Prevention Framework for
Prescription Drugs (SPF Rx): The
purpose of the SPF Rx grant program is
to provide resources to help prevent and
address prescription drug misuse within
a State or locality. The program is
designed to raise awareness about the
dangers of sharing medications as well
as the risks of fake or counterfeit pills
purchased over social media or other
unknown sources, and work with
pharmaceutical and medical
communities on the risks of
overprescribing. Whether addressed at
the state level or by an informed
community-based organization, the SPF
Rx program will raise community
awareness and bring prescription
substance misuse prevention activities
and education to schools, communities,
parents, prescribers, and their patients.
In addition, grant recipients will be
required to track reductions in opioid
related overdoses and incorporate
relevant prescription and overdose data
E:\FR\FM\24SEN1.SGM
24SEN1
Federal Register / Vol. 89, No. 185 / Tuesday, September 24, 2024 / Notices
into strategic planning and future
programming.
• First Responders-Comprehensive
Addiction and Recovery Act (FR CARA):
The purpose of this program is to allow
first responders and members of other
key community sectors to administer a
drug or device approved or cleared
under the Federal Food, Drug, and
Cosmetic Act for emergency treatment
of known or suspected opioid overdose.
• Grants to Prevent Prescription
Drug/Opioid Overdose-Related Deaths
(PDO): The purpose of this program is
to support first responders and members
of other key community sectors to
administer a drug or device approved or
cleared under the Federal Food, Drug,
and Cosmetic Act (FD&C Act) for
emergency reversal of known or
suspected opioid overdose. Recipients
will train and provide resources to first
responders and members of other key
community sectors at the state, tribal,
and local levels on carrying and
administering a drug or device approved
or cleared under the FD&C Act for
emergency treatment of known or
suspected opioid overdose.
• Improving Access to Overdose
Treatment (ODTA): The purpose of this
program is to expand access to naloxone
and other Food and Drug
Administration (FDA) approved
overdose reversal medications for
emergency treatment of known or
suspected opioid overdose. The
recipients will collaborate with other
prescribers at the community level to
implement trainings on policies,
procedures, and models of care for
prescribing, co-prescribing, and
expanding access to naloxone and other
FDA-approved overdose reversal
medications to the specified population
of focus (i.e., rural or urban). With this
program SAMHSA aims to expand
access to naloxone and other FDA
approved overdose reversal medications
for emergency treatment of known or
suspected opioid overdose.
Grant compliance monitoring: All
SAMHSA awards require grantees to
submit performance and progress
reports through the electronic Research
Administration (eRA) Commons, an
end-to-end Grants Management system.
The frequency and program-specific
instructions for preparation and
submission of these reports are
identified in the terms and conditions
found in the Notice of Award. CSAP
discretionary grant compliance
monitoring will be conducted through
the submission of the Programmatic
Progress Report (PPR). The PPR contains
fields for grantees to enter information
on activities and accomplishments that
occurred during the reporting period
77877
based on identified goals and objectives.
It also contains fields for grantees to
share evaluation updates and outcomes
as well as planned activities for the
upcoming reporting period as well as
any challenges that grantees have
experienced.
The Center for Substance Abuse
Prevention Online Reporting Tool
(CORT) is comprised of two
components. The first provides fields
for grantees to enter annual goals for key
programmatic measures. The second
provides fields for reporting quarterly
progress toward achieving these goals.
CSAP intends to have grantees report
progress on a quarterly basis to allow for
consistent, periodic analyses which will
allow for the administration of technical
assistance supports when grantees are
falling behind in achieving these goals.
Quarterly reporting will also allow the
Center to review the overall progress of
grant programs. Program specific
instruments have been developed to
ensure optimal alignment with
individual grant requirements. These
instruments were developed based on
instruments approved in OMB 0930–
0391: Harm Reduction Grant Program
Annual Targets and Quarterly Progress
Reports.
Annualized Data Collection Burden
TABLE 1—BURDEN TABLE: ANNUALIZED BURDEN—ANNUAL TARGETS
Instrument
Number of
respondents
Responses
per
respondent
Total
number of
responses
Hours per
response
Total burden
hours
Average
hourly wage 1
Total
respondent
cost
STOP Act .....................
SPF–PFS .....................
FR CARA .....................
PDO .............................
ODTA ...........................
SPF–Rx ........................
202
315
87
18
8
27
1
1
1
1
1
1
202
315
87
18
8
27
1
1
1
1
1
1
202
315
87
18
8
27
$48.35
48.35
48.35
48.35
48.35
48.35
9,766.70
15,230.25
4,206.45
870.30
386.80
1,305.45
Total ......................
657
........................
657
........................
657
........................
31,765.96
TABLE 2—BURDEN TABLE: CENTER FOR SUBSTANCE ABUSE PREVENTION ON-LINE REPORT TOOL (CORT)—QUARTERLY
PERFORMANCE ANNUALIZED BURDEN
lotter on DSK11XQN23PROD with NOTICES1
Instrument
Number of
respondents
Responses
per
respondent
Total
number of
responses
Hours per
response
Total burden
hours
Average
hourly wage 1
Total
respondent
cost
STOP Act .....................
SPF–PFS .....................
FR CARA .....................
PDO .............................
ODTA ...........................
SPF–Rx ........................
202
315
87
18
8
27
4
4
4
4
4
4
808
1,260
348
72
32
108
5.75
6
6
6
6
6
4,646
7,560
2,088
432
192
648
$48.35
48.35
48.35
48.35
48.35
48.35
224,634.10
365,526.00
100,954.80
20,887.20
9,283.20
31,330.80
Total ......................
657
........................
2,628
........................
15,566
........................
752,616.10
1 Grantee Project Director or Evaluator hourly wage is based on the mean hourly wage for state government managers, as reported in the
2022 Occupational Employment (OES) by the Bureau of Labor Statistics (BLS) found at https://www.bls.gov/oes/current/naics4_999200.htm#110000. Accessed on December 13, 2023.
VerDate Sep<11>2014
18:07 Sep 23, 2024
Jkt 262001
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
E:\FR\FM\24SEN1.SGM
24SEN1
77878
Federal Register / Vol. 89, No. 185 / Tuesday, September 24, 2024 / Notices
TABLE 3—ANNUALIZED BURDEN TABLE: CSAP’S GRANT PROGRAMMATIC PROGRESS REPORT
CSAP grant program
Number of
respondents
Responses
per
respondent
Total
number of
responses
Hours per
response
Total burden
hours
Average
hourly wage 1
Total
respondent
cost
STOP Act .....................
SPF–PFS .....................
FR CARA .....................
PDO .............................
ODTA ...........................
SPF Rx .........................
202
315
87
18
8
27
1
1
1
1
1
1
202
315
87
18
8
27
4
4
4
4
4
4
808
1,260
348
72
32
108
$48.35
48.35
48.35
48.35
48.35
48.35
39,066.80
60,921.00
16,825.80
3,481.20
1,547.20
5,221.80
Total ......................
657
........................
........................
........................
2,628
........................
127,063.80
TABLE 4—BURDEN TOTALS BY YEAR: ALL DATA COLLECTION INSTRUMENTS
Number of
grantees
Year
Total burden
hours
Average
hourly wage 1
Total cost
..................................................................................
..................................................................................
..................................................................................
..................................................................................
..................................................................................
657
700
700
700
700
∼28–29
29
29
29
29
18,851
20,088
20,088
20,088
20,088
$48.35
48.35
48.35
48.35
48.35
911,445.85
971,254.80
971,254.80
971,254.80
971,254.80
Total ..............................................................................
3,457
........................
99,203
........................
4,796,465.05
Year
Year
Year
Year
Year
1
2
3
4
5
The instruments have been revised to
reflect comments received during the
60-day Federal Register comment
period and cognitive testing. Changes
include adding/updating instructions
for clarification, added skip patterns,
adding/revising definitions,
standardizing language, collapsing of
response items, and removal of
measures. This will ease burden on
respondents. Additionally, adjustments
have been made in the language related
to reporting race/ethnicity and sexual
orientation and gender identity.
Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
Alicia Broadus,
Public Health Advisor.
[FR Doc. 2024–21789 Filed 9–23–24; 8:45 am]
BILLING CODE 4162–20–P
lotter on DSK11XQN23PROD with NOTICES1
Annual
burden hours
VerDate Sep<11>2014
18:07 Sep 23, 2024
Jkt 262001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Submission for the Office of
Management and Budget (OMB)
Review; Comment Request
Periodically, the Substance Abuse and
Mental Health Services Administration
(SAMHSA) will publish a summary of
information collection requests under
OMB review, in compliance with the
Paperwork Reduction Act (44 U.S.C.
chapter 35). To request a copy of these
documents, call the SAMHSA Reports
Clearance Officer on (240) 276–0361.
Project: Revision of Mental Health
Client/Participant Outcome Measures
and Infrastructure, Prevention, and
Promotion Indicators (OMB No. 0930–
0285)
SAMHSA is requesting approval from
OMB for a revision to extend the
expiration date for the previously
approved instruments and data
collection activities for the Center for
Mental Health Services Mental Health
Client/Participant Outcome Measures
and Infrastructure, Prevention, and
Promotion Indicators (OMB No 0930–
0285) that expires on March 30, 2025.
To be fully accountable for the
spending of Federal funds, SAMHSA
requires all programs to collect and
report data to ensure that program goals
and objectives are met. Data are
collected and used to monitor and
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
improve performance of each program
and ensure appropriate and thoughtful
spending of Federal funds.
SAMHSA requests to continue using
and extend the expiration date for the
currently approved Client-level Mental
Health Client/Participant Outcome
measures and Infrastructure, Prevention,
and Promotion indicators and to extend
the expiration date.
These two data collections maintain
capacity and requirements to report
qualitative performance and
quantitative outcomes for all Center for
Mental Health Services discretionary
grant programs, including: demographic
characteristics of clients served; social
determinants of health of clients served
before, during, and at end of services;
numbers of clients served; and process
measures, outputs, outcomes, of grant
program required activities.
Currently, the information collected
from these data collections is entered
and stored on SAMHSA’s Performance
Accountability and Reporting System
(SPARS), which is a real-time,
performance management system that
captures information on mental health
and substance abuse treatment services
delivered in the United States through
discretionary grantees. Continued
approval of this information collection
will allow SAMHSA to continue to meet
Government Performance and Results
Modernization Act of 2010 (GPRMA)
reporting requirements that quantify the
effects and accomplishments of its
discretionary grant programs, which are
consistent with OMB guidance.
E:\FR\FM\24SEN1.SGM
24SEN1
]]>Agencies
[Federal Register Volume 89, Number 185 (Tuesday, September 24, 2024)]
[Notices]
[Pages 77876-77878]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-21789]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Agency Information Collection Activities: Submission for OMB
Review; Comment Request
Periodically, the Substance Abuse and Mental Health Services
Administration (SAMHSA) will publish a summary of information
collection requests under OMB review, in compliance with the Paperwork
Reduction Act (44 U.S.C. chapter 35). To request a copy of these
documents, call the SAMHSA Reports Clearance Officer on (240) 276-0361.
Proposed Project: New: The Center for Substance Abuse Prevention
Online Reporting Tool and Grant Programmatic Progress Report to replace
Division of State Programs--Management Reporting Tool (DSP-MRT) (OMB
No. 0930-0354).
The Substance Abuse and Mental Health Services Administration's
(SAMHSA), Center for Substance Abuse Prevention (CSAP) is requesting
approval from the Office of Management and Budget (OMB) to monitor CSAP
discretionary grant programs through administration of a suite of data
collection instruments for grant compliance and programmatic
performance monitoring.
This package describes the data collection activities and proposed
instruments. Grant compliance monitoring will be conducted via a single
data collection instrument to be completed by all CSAP discretionary
grant recipients. Programmatic performance monitoring will be conducted
via a suite of data collection instruments with each instrument
tailored to a specific CSAP discretionary program. This request for
data collection will replace OMB No. 0930-0354: Division of State
Programs--Management Reporting Tool.
CSAP intends to monitor six grant programs through this data
collection effort:
Strategic Prevention Framework--Partnerships for Success
(SPF-PFS): The purpose of the SPF-PFS program is to help reduce the
onset and progression of substance misuse and its related problems by
supporting the development and delivery of state and community
substance misuse prevention and mental health promotion services. This
program is intended to promote substance use prevention throughout a
state jurisdiction for individuals and families by building and
expanding the capacity of local community prevention providers to
implement evidence-based programs. In addition, the program is intended
to expand and strengthen the capacity of local community prevention
providers to implement evidence-based prevention programs. With this
program, SAMHSA aims to strengthen state and community level prevention
capacity to identify and address local substance use prevention
concerns, such as underage drinking, marijuana, tobacco, electronic
cigarettes, opioids, methamphetamine, and heroin.
Sober Truth on Preventing Underage Drinking (STOP Act):
The purpose of this program is to prevent and reduce alcohol use among
youth and young adults ages 12-20 in communities throughout the United
States through evidence-based screening, programs and curricula, brief
intervention strategies, consistent policy enforcement, and
environmental changes that limit underage access to alcohol as
authorized by 42 U.S.C. 290bb-25b. The program aims to: (1) address
norms regarding alcohol use by youth, (2) reduce opportunities for
underage drinking, (3) create changes in underage drinking enforcement
efforts, (4) address penalties for underage use, and/or (5) reduce
negative consequences associated with underage drinking.
Strategic Prevention Framework for Prescription Drugs (SPF
Rx): The purpose of the SPF Rx grant program is to provide resources to
help prevent and address prescription drug misuse within a State or
locality. The program is designed to raise awareness about the dangers
of sharing medications as well as the risks of fake or counterfeit
pills purchased over social media or other unknown sources, and work
with pharmaceutical and medical communities on the risks of
overprescribing. Whether addressed at the state level or by an informed
community-based organization, the SPF Rx program will raise community
awareness and bring prescription substance misuse prevention activities
and education to schools, communities, parents, prescribers, and their
patients. In addition, grant recipients will be required to track
reductions in opioid related overdoses and incorporate relevant
prescription and overdose data
[[Page 77877]]
into strategic planning and future programming.
First Responders-Comprehensive Addiction and Recovery Act
(FR CARA): The purpose of this program is to allow first responders and
members of other key community sectors to administer a drug or device
approved or cleared under the Federal Food, Drug, and Cosmetic Act for
emergency treatment of known or suspected opioid overdose.
Grants to Prevent Prescription Drug/Opioid Overdose-
Related Deaths (PDO): The purpose of this program is to support first
responders and members of other key community sectors to administer a
drug or device approved or cleared under the Federal Food, Drug, and
Cosmetic Act (FD&C Act) for emergency reversal of known or suspected
opioid overdose. Recipients will train and provide resources to first
responders and members of other key community sectors at the state,
tribal, and local levels on carrying and administering a drug or device
approved or cleared under the FD&C Act for emergency treatment of known
or suspected opioid overdose.
Improving Access to Overdose Treatment (ODTA): The purpose
of this program is to expand access to naloxone and other Food and Drug
Administration (FDA) approved overdose reversal medications for
emergency treatment of known or suspected opioid overdose. The
recipients will collaborate with other prescribers at the community
level to implement trainings on policies, procedures, and models of
care for prescribing, co-prescribing, and expanding access to naloxone
and other FDA-approved overdose reversal medications to the specified
population of focus (i.e., rural or urban). With this program SAMHSA
aims to expand access to naloxone and other FDA approved overdose
reversal medications for emergency treatment of known or suspected
opioid overdose.
Grant compliance monitoring: All SAMHSA awards require grantees to
submit performance and progress reports through the electronic Research
Administration (eRA) Commons, an end-to-end Grants Management system.
The frequency and program-specific instructions for preparation and
submission of these reports are identified in the terms and conditions
found in the Notice of Award. CSAP discretionary grant compliance
monitoring will be conducted through the submission of the Programmatic
Progress Report (PPR). The PPR contains fields for grantees to enter
information on activities and accomplishments that occurred during the
reporting period based on identified goals and objectives. It also
contains fields for grantees to share evaluation updates and outcomes
as well as planned activities for the upcoming reporting period as well
as any challenges that grantees have experienced.
The Center for Substance Abuse Prevention Online Reporting Tool
(CORT) is comprised of two components. The first provides fields for
grantees to enter annual goals for key programmatic measures. The
second provides fields for reporting quarterly progress toward
achieving these goals. CSAP intends to have grantees report progress on
a quarterly basis to allow for consistent, periodic analyses which will
allow for the administration of technical assistance supports when
grantees are falling behind in achieving these goals. Quarterly
reporting will also allow the Center to review the overall progress of
grant programs. Program specific instruments have been developed to
ensure optimal alignment with individual grant requirements. These
instruments were developed based on instruments approved in OMB 0930-
0391: Harm Reduction Grant Program Annual Targets and Quarterly
Progress Reports.
Annualized Data Collection Burden
Table 1--Burden Table: Annualized Burden--Annual Targets
--------------------------------------------------------------------------------------------------------------------------------------------------------
Total
Instrument Number of Responses per Total number Hours per Total burden Average hourly respondent
respondents respondent of responses response hours wage \1\ cost
--------------------------------------------------------------------------------------------------------------------------------------------------------
STOP Act................................ 202 1 202 1 202 $48.35 9,766.70
SPF-PFS................................. 315 1 315 1 315 48.35 15,230.25
FR CARA................................. 87 1 87 1 87 48.35 4,206.45
PDO..................................... 18 1 18 1 18 48.35 870.30
ODTA.................................... 8 1 8 1 8 48.35 386.80
SPF-Rx.................................. 27 1 27 1 27 48.35 1,305.45
---------------------------------------------------------------------------------------------------------------
Total............................... 657 .............. 657 .............. 657 .............. 31,765.96
--------------------------------------------------------------------------------------------------------------------------------------------------------
Table 2--Burden Table: Center for Substance Abuse Prevention On-Line Report Tool (CORT)--Quarterly Performance Annualized Burden
--------------------------------------------------------------------------------------------------------------------------------------------------------
Total
Instrument Number of Responses per Total number Hours per Total burden Average hourly respondent
respondents respondent of responses response hours wage \1\ cost
--------------------------------------------------------------------------------------------------------------------------------------------------------
STOP Act................................ 202 4 808 5.75 4,646 $48.35 224,634.10
SPF-PFS................................. 315 4 1,260 6 7,560 48.35 365,526.00
FR CARA................................. 87 4 348 6 2,088 48.35 100,954.80
PDO..................................... 18 4 72 6 432 48.35 20,887.20
ODTA.................................... 8 4 32 6 192 48.35 9,283.20
SPF-Rx.................................. 27 4 108 6 648 48.35 31,330.80
---------------------------------------------------------------------------------------------------------------
Total............................... 657 .............. 2,628 .............. 15,566 .............. 752,616.10
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ Grantee Project Director or Evaluator hourly wage is based on the mean hourly wage for state government managers, as reported in the 2022
Occupational Employment (OES) by the Bureau of Labor Statistics (BLS) found at https://www.bls.gov/oes/current/naics4_999200.htm#11-0000. Accessed on
December 13, 2023.
[[Page 77878]]
Table 3--Annualized Burden Table: CSAP's Grant Programmatic Progress Report
--------------------------------------------------------------------------------------------------------------------------------------------------------
Total
CSAP grant program Number of Responses per Total number Hours per Total burden Average hourly respondent
respondents respondent of responses response hours wage \1\ cost
--------------------------------------------------------------------------------------------------------------------------------------------------------
STOP Act................................ 202 1 202 4 808 $48.35 39,066.80
SPF-PFS................................. 315 1 315 4 1,260 48.35 60,921.00
FR CARA................................. 87 1 87 4 348 48.35 16,825.80
PDO..................................... 18 1 18 4 72 48.35 3,481.20
ODTA.................................... 8 1 8 4 32 48.35 1,547.20
SPF Rx.................................. 27 1 27 4 108 48.35 5,221.80
---------------------------------------------------------------------------------------------------------------
Total............................... 657 .............. .............. .............. 2,628 .............. 127,063.80
--------------------------------------------------------------------------------------------------------------------------------------------------------
Table 4--Burden Totals by Year: All Data Collection Instruments
----------------------------------------------------------------------------------------------------------------
Number of Annual burden Total burden Average hourly
Year grantees hours hours wage \1\ Total cost
----------------------------------------------------------------------------------------------------------------
Year 1.......................... 657 ~28-29 18,851 $48.35 911,445.85
Year 2.......................... 700 29 20,088 48.35 971,254.80
Year 3.......................... 700 29 20,088 48.35 971,254.80
Year 4.......................... 700 29 20,088 48.35 971,254.80
Year 5.......................... 700 29 20,088 48.35 971,254.80
-------------------------------------------------------------------------------
Total....................... 3,457 .............. 99,203 .............. 4,796,465.05
----------------------------------------------------------------------------------------------------------------
The instruments have been revised to reflect comments received
during the 60-day Federal Register comment period and cognitive
testing. Changes include adding/updating instructions for
clarification, added skip patterns, adding/revising definitions,
standardizing language, collapsing of response items, and removal of
measures. This will ease burden on respondents. Additionally,
adjustments have been made in the language related to reporting race/
ethnicity and sexual orientation and gender identity.
Written comments and recommendations for the proposed information
collection should be sent within 30 days of publication of this notice
to www.reginfo.gov/public/do/PRAMain. Find this particular information
collection by selecting ``Currently under 30-day Review--Open for
Public Comments'' or by using the search function.
Alicia Broadus,
Public Health Advisor.
[FR Doc. 2024-21789 Filed 9-23-24; 8:45 am]
BILLING CODE 4162-20-P
